Phase I trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

被引:0
作者
Mundi, P. S.
Lee, S.
Chi, D.
Bhardwaj, A.
Makower, D.
Cigler, T.
Crew, K. D.
Hershman, D. L.
Califano, A.
Silva, J.
Kalinsky, K. M.
机构
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Food & Drug Adm, Mt Sinai Sch Med, New York, NY USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
[4] Weill Cornell Med Ctr, New York, NY USA
关键词
D O I
10.1158/1538-7445.SABCS16-P4-21-37
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P4-21-37
引用
收藏
页数:2
相关论文
empty
未找到相关数据